Can a simple genetic test make Children's medications safer?
NCT ID NCT04249375
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a genetic test panel in 150 children who are taking common medications like painkillers, antibiotics, or mental health drugs. The goal is to see if the test can help doctors and pharmacists predict and prevent serious side effects. Researchers will also ask families and healthcare providers how useful and clear the test results are.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pharmacogenomic testing panel
- What this could lead to
- If successful, this could make prescribing safer for children by using genetic information to avoid harmful drug reactions.
- What could go wrong
- This is a small pilot study focused on feasibility, not on proving clinical outcomes. The results may not apply to all children or healthcare settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVERSE DRUG REACTION (ADR) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital of Eastern Ontario
RECRUITINGOttawa, Ontario, K1H 8L1, Canada
-
Children's and Women's Health Centre of British Columbia
RECRUITINGVancouver, British Columbia, V6H 3V4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.